Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

CYTO Altamira Therapeutics

0.292
-0.008-2.67%
Close 09/29 16:00 ET
0.2920.0000.00%
Post Mkt Price 09/29 16:00 ET
High
0.315
Open
0.315
Turnover
22.53K
Low
0.283
Pre Close
0.300
Volume
77.02K
Market Cap
5.89M
P/E(TTM)
Loss
52wk High
3.330
Shares
20.19M
P/E(Static)
Loss
52wk Low
0.230
Float Cap
5.37M
Bid/Ask %
-81.48%
Historical High
1592.000
Shs Float
18.40M
Volume Ratio
0.24
Historical Low
0.230
Dividend TTM
--
Div Yield TTM
--
P/B
0.43
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.42%
Amplitude
10.76%
Avg Price
0.292
Lot Size
1
Float Cap
5.37M
Bid/Ask %
-81.48%
Historical High
1592.000
Shs Float
18.40M
Volume Ratio
0.24
Historical Low
0.230
Dividend TTM
--
P/B
0.43
Dividend LFY
--
Turnover Ratio
0.42%
Amplitude
10.76%
Avg Price
0.292
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Altamira Therapeutics Ltd. engages in the development of novel products that address unmet medical needs in neurology and central nervous system disorders. It operates through the following geographical segments: United States, Switzerland, Europe, and Australia. Its product pipeline includes AM-125, AM-201, AM301, Sonsuvi, and Keyzilen. The company was founded by Thomas Meyer in April 2003 and is headquartered in Hamilton, Bermuda.
CEO: Mr. Thomas Meyer
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...